Page 99 - Characterization of genetic neurodevelopmental disorders at adult age, with a focus on 22q11.2 deletion syndrome - Emma Boersma

97
na na na na + na na na F
na na na na + na na na G
na na na na + na na na G
na na na na + na na na G
na na na na + na na na G
na na na na + na nr na G
na na na na + na na na F
na na na na + na na na G
na na na na - na nr na F
na na na na + na nr na G
na na na na + na nr na F
na na na na + na cd na G
na na na na + na na na G
na na na na + na na na G
Sufficient timeframe between
exposure and outcome
Different levels of the exposure
examined as related to the
outcome
Exposure measures clearly
defined, valid, reliable, and
implemented consistently
Exposure assessed more than
once over time
Outcome measures clearly
defined, valid, reliable, and
implemented consistently
Outcome assessors blinded to the
exposure status
Loss to follow-up 20% or less
Potential confounding variables
measured and adjusted
statistically
Rating
2
Parkinsonism in GNDs